The "cheerleader effect" in facial and bodily attractiveness: A result of memory bias and not perceptual encoding.

Individual faces are rated as more attractive when presented in a group compared with when presented individually; a finding dubbed the "cheerleader effect." As a relatively recent discovery, the conditions necessary to observe the effect are not clearly understood. We sought to better define these conditions by examining two parameters associated with the effect. Our first aim was to determine whether the effect is specific to faces or occurs also for human bodies. Both face and body images were rated as being more attractive when presented in groups than when presented in isolation, demonstrating that the cheerleader effect is not restricted to faces. Furthermore, the effect was significantly larger for bodies than faces. Our second aim was to determine whether the cheerleader effect originates from a bias in memory or occurs during perceptual encoding. Participants in the "memory" condition provided attractiveness ratings after images had been removed from the testing screen, whereas participants in the "perceptual" condition provided ratings while the images remained visible, thereby eliminating the memory components of the paradigm. Significant cheerleader effects were only observed in the memory condition. We conclude that the cheerleader effect for faces and bodies is due to a bias in memory and does not occur at an initial stage of perceptual encoding.

A sleeping phantom leg awakened following hemicolectomy, thrombosis, and chemotherapy: a case report.

INTRODUCTION: We describe the case of a patient who experienced phantom pain that began 42 years after right above-the-knee amputation. Immediately prior to phantom pain onset, this long-term amputee had experienced, in rapid succession, cancer, hemicolectomy, chemotherapy, and thrombotic occlusion. Very little has been published to date on the association between chemotherapy and exacerbation of neuropathic pain in amputees, let alone the phenomenon of bringing about pain in amputees who have been pain-free for many decades. While this patient presented with a unique profile following a rare sequence of medical events, his case should be recognized considering the frequent co-occurrence of osteomyelitis, chemotherapy, and amputation. CASE PRESENTATION: A 68-year-old Australian Caucasian man presented 42 years after right above-the-knee amputation with phantom pain immediately following hemicolectomy, thrombotic occlusion in the amputated leg, and chemotherapy treatment with leucovorin and 5-fluorouracil. He exhibited probable hyperalgesia with a reduced pinprick threshold and increased stump sensitivity, indicating likely peripheral and central sensitization. CONCLUSION: Our patient, who had long-term nerve injury due to amputation, together with recent ischemic nerve and tissue injury due to thrombosis, exhibited likely chemotherapy-induced neuropathy. While he presented with unique treatment needs, cases such as this one may actually be quite common considering that osteosarcoma can frequently lead to amputation and be followed by chemotherapy. The increased susceptibility of amputees to developing potentially intractable chemotherapy-induced neuropathic pain should be taken into consideration throughout the course of chemotherapy treatment. Patients in whom chronic phantom pain then develops, perhaps together with mobility issues, inevitably place greater demands on healthcare service providers that require treatment by various clinical specialists, including oncologists, neurologists, prosthetists, and, most frequently, general practitioners.